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Background:MicroRNAmiR-199a-5p, implicated in cell motility and proliferation, is highly expressed in bladder smooth
muscle.
Results: MiR-199a-5p regulates WNT, cytoskeleton, and cell cycle pathways in urothelial and smooth muscle cells and pro-
motes myocardin-driven gene expression.
Conclusion:MiR-199a-5p acts via its target WNT2 to control smooth muscle proliferation and morphology.
Significance:MiR-199a-5p is a key modulator of smooth muscle hypertrophy, relevant for bladder organ remodeling.
MicroRNA miR-199a-5p impairs tight junction formation,
leading to increased urothelial permeability in bladder pain syn-
drome. Now, using transcriptome analysis in urothelial TEU-2
cells, we implicate it in the regulation of cell cycle, cytoskeleton
remodeling, TGF, and WNT signaling pathways. MiR-199a-5p
is highly expressed in the smooth muscle layer of the bladder,
and we altered its levels in bladder smooth muscle cells (SMCs)
to validate the pathway analysis. Inhibition ofmiR-199a-5pwith
antimiR increased SMC proliferation, reduced cell size, and up-
regulated miR-199a-5p targets, including WNT2. Overexpres-
sion of WNT2 protein or treating SMCs with recombinant
WNT2 closely mimicked the miR-199a-5p inhibition, whereas
down-regulation of WNT2 in antimiR-expressing SMCs with
shRNA restored cell phenotype and proliferation rates. Overex-
pression of miR-199a-5p in the bladder SMCs significantly
increased cell size and up-regulated SM22, SM -actin, and SM
myosin heavy chainmRNA and protein levels. These changes as
well as increased expression ofACTG2,TGFB1I1, andCDKN1A
were mediated by up-regulation of the smooth muscle-specific
transcriptional activator myocardin at mRNA and protein lev-
els. Myocardin-related transcription factor A downstream tar-
gets Id3 andMYL9were also induced. Up-regulation ofmyocar-
din was accompanied by down-regulation of WNT-dependent
inhibitory Krüppel-like transcription factor 4 in miR-199a-5p-
overexpressing cells. In contrast, Krüppel-like transcription fac-
tor 4 was induced in antimiR-expressing cells following the
activation of WNT2 signaling, leading to repression of myocar-
din-dependent genes. MiR-199a-5p plays a critical role in the
WNT2-mediated regulation of proliferative and differentiation
processes in the smooth muscle andmay behave as a key modu-
lator of smoothmuscle hypertrophy, which is relevant for organ
remodeling.
The main functions of the urinary bladder are urine storage
and voiding. Normally, the bladder fills without distinct sensa-
tions and with no or only a marginal increase in intravesical
pressure. However, in lower urinary tract dysfunction, this
process is impaired by symptoms of urgency, frequency, and
incomplete emptying. Lower urinary tract dysfunction causes
profound changes in the gene expression profiles of both blad-
der urothelium and smooth muscle: in human bladder pain
syndrome (BPS)2 patients, the proteoglycan core proteins (1)
and the tight junction proteins ZO-1, junctional adhesion mol-
ecule 1, and occludin (2) were down-regulated, implicating
increased urothelial permeability. Bladder smoothmuscle has a
high level of plasticity and undergoes remodeling during lower
urinary tract dysfunctions (3, 4). Benign prostatic hyperplasia
can lead to bladder outlet obstruction accompanied by bladder
hypertrophy (5). Bladder hypertrophy is characterized by sig-
nificant changes in the expression profile of smooth muscle
contractile and signaling proteins andmodification of extracel-
lular matrix proteins (6, 7).
MicroRNAs (miRNAs) are quickly gaining recognition for
their role in many biological processes and disease states (8).
MiRNAs are endogenous non-coding single-stranded RNAs of
22 nucleotides that regulate gene expression by post-tran-
scriptional mechanisms upon sequence-specific binding to
their mRNA targets. MiRNAs are important modulators of
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gene expression, and dysregulation of their synthesis contrib-
utes to many human diseases (9, 10). The first miRNA profiling
in BPS has identified several miRNAs regulating the expression
of signaling and adhesionmolecules (2) that are relevant for the
disease pathogenesis. The comparative analysis of the miRNA
expression profiles in BPS, bladder cancer, and several inflam-
matory disorders showed that seven of 31 miRNAs altered in
BPS had the same regulatory pattern in inflammatory bowel
disease (11), which shares many features with BPS (12).
Recently, the role ofmiRNAs in the bladder smoothmuscle was
investigated using an induced smooth muscle-specific Dicer
knock-out, which caused a significant reduction of miRNA lev-
els, including miR-145, miR-143, miR-22, miR-125b-5p, and
miR-27a, leading to a disturbedmicturition pattern in vivo (13).
In a similar study, the loss of Dicer exacerbated cyclophos-
phamide-induced bladder overactivity in mice (14). MiR-29 is
down-regulated in obstructed bladders, leading to increased
ECM accumulation and fibrosis (15). Connexin 43 (GJA1), a
major gap junction protein in bladder smooth muscle involved
in regulation of contractility, has been shown to be repressed by
themyocardin-responsivemuscle-specific miR-1 with implica-
tions for postnatal bladder development and overactivity (16).
Previously, we identified miR-199a-5p as an important regu-
lator of intercellular junctions (17). Upon overexpression in
urothelial cells, it impairs correct tight junction formation and
leads to increased permeability. MiR-199a-5p directly targets
mRNAs encoding LIN7C, ARHGAP12, PALS1, RND1, and
PVRL1 and attenuates their expression levels to a similar
extent. The multiplicity of miR-199a-5p targets involved in the
regulation of actin cytoskeleton and tight and adherens junc-
tion formation prompted us to carry out a comprehensive anal-
ysis of its effects on the transcriptome of transfected TEU-2
cells. Here, using next generation mRNA sequencing (RNA-
seq) followed by GeneGoMetaCore pathway analysis, we iden-
tified the major signaling pathways regulated by this miRNA,
includingWNT signaling, cytoskeletal, and cell cycle pathways.
Our previous laser microdissection studies have shown that
miR-199a-5p was predominantly expressed in bladder smooth
muscle (17). We sought to elucidate its function in the bladder
smooth muscle cells (SMCs) and investigated the effects of the
alteration of its levels with antimiR- and miR-overexpressing
lentiviral vectors on the smooth muscle morphology. We
report that miR-199a-5p is a crucial regulator of the WNT sig-
naling pathway in both TEU-2 and bladder SMCs, and it affects
the proliferative and differentiation processes in the bladder
smooth muscle.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies
Monoclonal antibodies against smooth muscle (SM) -actin
(1A4) (A 2547), SM myosin heavy chain (M7786), and caldes-
mon (C21) (C0297) were from Sigma. Polyclonal anti-WNT2
antibody (ab27794) was from Abcam. Polyclonal anti-myocar-
din (sc-33766) and anti-inhibitor of DNA-binding protein 3
(Id3) (sc-490) and monoclonal anti- myocardin-related tran-
scription factor (MRTF)-A (sc-398675) were from Santa Cruz
Biotechnology, Inc. Alexa Fluor 488- and Cy3-labeled phalloi-
dins were from Molecular Probes (Invitrogen). Restriction
endonucleases, Taq polymerase, and T4 DNA ligase were pur-
chased from New England Biolabs. Chemicals were from
Sigma. Recombinant human DKK1 was from Sigma, and
recombinant humanWNT2 was from Abnova. The cell prolif-
eration ELISA (BrdU) was from Roche Applied Science.
G-LISA RhoA, Rac1, and Cdc42 kits were from Cytoskeleton,
Inc.
Cell Culture and Transfection
The immortalized human urothelial cell line TEU-2 (18) was
maintained in serum-free EpiLife Medium (Gibco, Life Tech-
nologies) supplemented with human keratinocyte growth sup-
plement and antibiotics (Gibco, Life Technologies). Differenti-
ation of TEU-2 cells was achieved by addition of serum and
Ca2 as described previously (19). Pre-miR miRNA precursors
for miR-199a-5p and a validated Cy3-labeled negative control
were fromAmbion (Applied Biosystems). The reverse transfec-
tions were done in 12-well plates with and without inserts (BD
Biosciences, Falcon) using siPORT NeoFX Transfection Agent
(Applied Biosystems). The transfected cells were incubated at
37 °C for 24, 48, or 72 h before mRNA isolation.
HEK293 cells were maintained in DMEM containing 2 mM
glutamine (Biochrom), 100 units of penicillin/ml, 100 g of
streptomycin/ml, and 10% FCS (Gibco, Life Technologies).
HEK293 cells were transiently transfected with reporter plas-
mids using Lipofectamine 2000 (Invitrogen) and assayed for
luciferase activity 24 h post-transfection. Primary cultures of
the human bladder SMCs were established following the papa-
in-collagenase protocol as described previously (20). Cells were
maintained in DMEM containing 2 mM glutamine, 100 units of
penicillin/ml, 100 g of streptomycin/ml, and 10% FCS. Cell
passages between 1 and 6 were used. All the cell cultures were
incubated at 37 °C at 85% humidity and 5% CO2. Cell prolifer-
ation and metabolic activity were assessed using Alamar Blue
reagent (Invitrogen) following the manufacturer’s instructions.
Total RNA Isolation, Reverse Transcription, and Real Time PCR
Analysis of mRNA andMiRNA Expression
Total RNAwas isolated using themiRVanamiRNA isolation
kit (Ambion) as described previously (2, 21). The reverse tran-
scription reactions were carried out using the High Capacity
cDNA Reverse Transcription kit (Applied Biosystems) with
random hexamer primers. The exon junction-spanning prim-
ers for SYBR Green quantitative real time PCR (QPCR) were
designed by using PrimerBLAST software. Melting tempera-
ture, self-complementarity, and 3 stability of primers were
checked by Primer3Plus software, and primers were synthe-
sized by Microsynth (Switzerland). TaqMan assays were from
Applied Biosystems. Assay numbers and SYBR primer pairs
used for QPCR are listed in supplemental file List of primers
and assays.xlsx. Quantification of mature miR-199a-5p and
endogenous control miRNA RNU48 was performed using
TaqMan assays 000498 and 001006with supplied assay-specific
RT primers (Applied Biosystems). QPCR was carried out in
triplicates using the 7900HT Fast Real-time PCR System
(Applied Biosystems). The Ct values obtained after QPCRwere
normalized to the 18 S rRNAwhen performing TaqManQPCR
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and to the 28 S rRNAwhen performing SYBR Green QPCR. Ct
values of miR-199a-5p TaqMan assay were normalized to
RNU48. The end products of all PCRs were analyzed on a 4%
low melting point agarose gel to validate the fragment size.
Firefly Luciferase Constructs and Luciferase Reporter Assays
A pmirGLO vector (Promega) containing the miR-199a-5p
target sequenceGAACAGGTAGTCTGAACACTGGGwas
used as a positive control as described previously (17). To detect
luciferase activity, the Dual-Luciferase Reporter Assay (Pro-
mega) was used, and the activity was normalized to Renilla
luciferase expressed from the pmirGLO vector.
SDS-PAGE andWestern Blotting Analysis
Unless otherwise stated, all procedures were performed at
4 °C or on ice. The cell lysates were analyzed by SDS-PAGE
followed by Western blotting with specific antibodies. Image
analysis to estimate the protein content of the individual bands
following SDS-PAGE and Western blotting was performed
using ImageJ software.
Phalloidin Staining and Live Cell Imaging
Bladder SMCs transduced with lentiviruses were grown on
poly-L-lysine- and laminin-coated glass coverslips. For phallo-
idin staining, the cells were fixed with 4% paraformaldehyde,
permeabilized in 0.05% Triton X-100 in PBS, and incubated
with theCy3- orAlexa Fluor 488-conjugated phalloidin. Inserts
were mounted in PBS-gelvatol and examined under an Axio-
vert 200 M microscope with laser scanning module LSM 510
META (Zeiss). Live cell imaging was performed as described
(22). Cells were observed under an Axiovert 200Mmicroscope
with laser scanning module LSM 510 META using a 20 or a
40 oil immersion lens. Cell size (m2) was evaluated on cap-
tured images using Zeiss LSM software.
Lentivirus Production and Transduction of Bladder SM Cells
Total RNA was isolated from bladder SM cells, and cDNA
was produced by reverse transcription with random hexamer
primers as described above. Coding sequence of WNT2 was
PCR-amplified using forward primer 5-AT AAA GCTAGC
ATG AAC GCC CCT CTC GGTG-3 and reverse primer
5-ATA AA GGATCC TGT AGC GGT TGT CCA GTC
AG-3. Cloning NheI and BamHI sites are underlined. PCR
fragments were inserted into pCDH-EF1-T2A-copGFP vector
(System Biosciences, Mountain View, CA) to produce pCDH-
WNT2 lentiviral vector. Lentiviral vectors overexpressing non-
targeting scrambled miRNA, miR-199a-5p, and antimiR-
199a-5p were as described previously (27). Lentiviruses
expressing shRNA clones for WNT2 and a scrambled shRNA
control, tagged with pmCherry, were from OmicsLinkTM
shRNA Expression Clones, GeneCopoeia (Rockville, MD) (cat-
alog number HSH018529-1-LVRU6MP). The WNT2 target
sequences of the shRNA clones were as follows: clone 1, TCC
TGT GAT CCA AAG AAGA; clone 2, GGC TGC AGT GAT
AAC ATTG; clone 3, TGT GGC CTT TAT CTC AACG; and
clone 4, CCT GGA GAA GAA TGG CTTT. HEK293FT cells
(System Biosciences) were plated at 50% confluence on 10-cm
dishes and transfected with 12.5g of each of the pCDH-based
lentiviral vectors, 7.5 g of packaging pPAX2, and 4 g of
pMD2.G plasmids using Lipofectamine 2000 following the
manufacturer’s instructions. Supernatants collected 24 and
48 h after transfection were centrifuged at 4000  g, filtered
through a 0.45-m-pore size cellulose acetate filter (Millipore,
Billerica, MA), and mixed with PEG-it Virus Concentration
Solution (System Biosciences) overnight at 4 °C. Viruses were
precipitated at 1500 g at 4 °C the next day and resuspended in
PBS. The number of transducing infectious units of each stock
was determined by infection of 293T cells followed by assessing
the percentage of GFP-positive cells by fluorescence-activated
cell sorting (FACS).
Subconfluent cultures of the primary bladder SMCs were
transduced with recombinant lentiviral particles using 5 106
transducing infectious units/1  106 cells in the presence of 8
g/ml Polybrene (Sigma). Typically, 70–95%cellswere fluores-
cent reporter-positive 72 hpost-transduction. Transduced cells
were propagated and used in assays as described above.
Illumina RNA Sequencing
Library Preparation—The quality of the isolated RNA was
determined with a Qubit (1.0) fluorometer (Life Technolo-
gies) and a Bioanalyzer 2100 (Agilent, Waldbronn, Germany).
Only those samples with a 260/280 nm ratio between 1.8 and
2.1 and a 28 S/18 S ratio within 1.5–2 were further processed.
The TruSeq RNA Sample Prep kit v2 (Illumina, Inc.) was used
in the succeeding steps. Briefly, total RNA samples (100–1000
ng) were poly(A)-enriched and then reverse transcribed into
double-stranded cDNA. The cDNA samples were fragmented,
end-repaired, and polyadenylated before ligation of TruSeq
adapters containing the index formultiplexing. Fragments con-
taining TruSeq adapters on both ends were selectively enriched
with PCR. The quality and quantity of the enriched libraries
were validated using a Qubit (1.0) fluorometer and the Caliper
LabChip GX (Caliper Life Sciences, Inc.). The product is a
smear with an average fragment size of260 bp. The libraries
were normalized to 10 nM in 10 mM Tris-Cl, pH 8.5 with 0.1%
Tween 20.
Cluster Generation and Sequencing—The TruSeq PE Cluster
kit v3-cBot-HS or TruSeq SR Cluster kit v3-cBot-HS (Illumina,
Inc.) was used for cluster generation using 10 pM pooled nor-
malized libraries on the cBot. Sequencing were performed on
the Illumina HiSeq 2000 paired end at 2 101 bp or single end
100 bp using the TruSeq SBS kit v3-HS (Illumina, Inc.). Isoform
expression was quantified using RSEM v1.1.15 (23). As a refer-
ence, we used the gene definitions from the University of Cali-
fornia Santa Cruz for genome build hg19. RSEM was run with
default parameters. Differential expression was computed with
the Bioconductor package DESeq 1.4.1 (24). All hierarchical
clusterings and the associated heat maps related to sequencing
data were generated with the function heatmap2 in the R pack-
age gplots. For heatmap visualization, the log expression values
were used, and the values were normalized per gene by sub-
tracting the mean.
Pathway Analysis
Transcripts with adjusted p value, false discovery rate q
0.05, and -fold change 1.5 were considered differentially
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FIGURE 1. Ectopic expression of miR-199a-5p in differentiated and non-differentiated TEU-2 cells causes profound changes in gene expression. The
TEU-2 cells transfected with pre-miR-199a-5p and negative control miR-Cy3 were grown on inserts in the presence of differentiation medium for 72 h (n 3
samples per group). Total RNA was harvested, and total transcriptome analysis was performed followingmRNA sequencing (next generation sequencing). A,
heatmap and hierarchical cluster analysis visualization of the log2 expression values obtained from 1646 genes. Values are normalized per gene. Color coding
specifies expression of a given gene relative to the expression across the six samples. A dendrogram of clusters is shown on the left of the heat map. The
expression level of a given gene is indicated by red (high) and green (low) in the heat map (significance threshold, 0.01; log2 ratio threshold, 0.5). The -fold
changes between samples are variable, but there is a tight linear expression pattern for each gene, and the variability is due to selection of 1	 Correlation as
ameasure of distance. B, results for 53 genes included in further QPCR validation studies. C, effect ofmicroRNAmir-199a-5p expression in differentiated versus
non-differentiated TEU-2 cells. The heat map compares expression of 65 genes in TEU-2 cells in mir-199a-5p-transfected (MonomiR) and mir-199a-5p-
transfected differentiated (DifmiR) TEU-2 cells. A panel of 65 genes was investigated by QPCR (primers and assays are shown in supplemental file List of
primers and assays.xlsx) using cDNA frommiR-overexpressing differentiated or non-differentiated (monolayer) TEU-2 cells. The rows correspond to different
genes, and the columns represent the average of three experimental samples. The expression levels of genes in miR-199a-5p-transfected cells are shown as
-fold changes relative to control non-targetingmiR-Cy3 samples inmonolayers anddifferentiated TEU-2 cells, respectively. The city blockdistancemethodwas
used to calculate thedistance for clusteringof thegenes and samples.Genesof the knownmiR-199a-5p targets aredown-regulated inboth samplegroupsand
clustered apart from those of involved in ECM and contraction. D, the mRNA levels were analyzed by QPCR, normalized to 28 S rRNA, and expressed as -fold
difference relative (rel.) to the average values for miR-Cy3 cultures (either differentiated or monolayer). The graph shows an average of three experiments
performed in triplicates
S.E. (error bars). All differences were statistically significant (p 0.05).
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expressed. Differentially expressed transcripts were then sub-
jected to GeneGo MetaCore from Thomson Reuters (version
6.19, build 65960) to identify enrichment of pathways and pro-
cesses using hypergeometric distributions to determine the
most enriched gene setswithMetaCore variation of the Fisher’s
exact test and adjusting formultiple sample testing false discov-
ery rate q0.05. Differentially affected pathways were defined
based on standard deviation of the	log(p value), and then the
resulting table of ontology was sorted in decreasing order of
those standard deviation values.
FIGURE 2.Culturing of bladder smoothmuscle cells induces gene expression changes.Human bladder SM sampleswere used to raise primary cultures of
SMCs. Cultureswerepassagedonce (P.1) and three times (P.3), and themRNA levels of selectedgenesweredeterminedbyQPCRand related to the levels in the
original SM samples. The results were normalized to 28 S rRNA for SYBRGreen primer pairs and 18 S rRNA for TaqMan assays and expressed relative (rel.) to the
average values in the bladder SM samples. Each experiment was performed in triplicate. A, mRNA levels of smoothmuscle-specific and contractile proteins; B,
ratio of myosin heavy chain isoform SM2 to SM1; C, genes regulated by WNT; D, connective tissue growth factor and ECM proteins; E, validated miR-199a-5p
targets; F, levels of mature miR-199a-5p were determined by QPCR, normalized to RNU48, and compared with the levels in SM tissue. The results of two
independent SMC preparations (prep 1 and prep 2) are shown. A–F, error bars represent S.E. Differences were statistically significant (p 0.05).
TABLE 1
Intersecting pathwaymaps regulated bymiR-199a-5p
Rank Common pathways log (p value)
1 Cytoskeleton remodeling via TGF, WNT 5.6
2 Signal transduction JNK pathway 4.1
3 Development WNT signaling pathway, part 2 3.6
4 Development regulation of epithelial-to-mesenchymal
transition
3.2
5 Cytoskeleton remodeling 3.1
6 Development TGF- receptor signaling 1.8
7 Cell cycle influence of Ras and Rho proteins on
G1/S transition
1.7
8 Cell adhesion chemokines and adhesion 1.7
MiR-199a-5p Regulates SmoothMuscle Proliferation
MARCH 13, 2015•VOLUME 290•NUMBER 11 JOURNAL OF BIOLOGICAL CHEMISTRY 7071
 at U
ZH
 H
auptbibliothek / Zentralbibliothek Zuerich on A
ugust 26, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
MiR-199a-5p Regulates SmoothMuscle Proliferation
7072 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 11•MARCH 13, 2015
 at U
ZH
 H
auptbibliothek / Zentralbibliothek Zuerich on A
ugust 26, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Statistical and Data Analysis
Statistically significant differences were determined with a
two-tailed Student’s t test preceded by a Levene’s test with set
to 0.05 for genes with a normal distribution. The results of cell
assays were analyzed using one-way analysis of variance fol-
lowed by Tukey’s multiple comparison test or a two-tailed
Student’s t test preceded by a Levene’s test. All studies were
carried out with the SPSS program (version 20.0). All hierarchi-
cal clusterings and the associated heat maps related to QPCR
data were generated with the function heatmap2 in the R pack-
age gplots. Unless otherwise stated, for heat map visualization,
the -fold change values were used, the values were normalized
per gene, and calculation of distance for clustering was done
based on city block distance (Manhattan distance) and the aver-
age linkage method.
RESULTS
RNA-seq Transcriptome Profiling of the Differentiated TEU-2
Cells Overexpressing miR-199a-5p—Our recent study identi-
fied miR-199a-5p as an important regulator of intercellular
junctions by targeting mRNAs encoding LIN7C, ARHGAP12,
PALS1, RND1, and PVRL1 (17). Taking into account the mul-
tiplicity of miR-199a-5p-regulated target transcripts, we per-
formed a comprehensive RNA-seq expression profiling of the
differentiated TEU-2 cells transfected with miR-199a-5p pre-
cursor or scrambled non-targeting miRNA control. Total RNA
sequencing resulted in 546 (paired end) million raw reads with
an average of 91 million raw sequencing reads ranging from 68
to 106 million reads per sample. Approximately 65% of the
total reads were recorded with at least one reported alignment
with reference genome hg19. Of these reads, an average of
43.7% corresponded to transcripts, 38.3% corresponded to
mRNA exons, 5.5% corresponded to mRNA introns, 2.4% cor-
responded to mRNA promoter 2 kb, and 4.0% corresponded to
mRNA downstream 2 kb (supplemental file Read count infor-
mation.xlsx). About 30% of the mapped reads spanned two
junctions, and 60% of themapped reads spanned only one junc-
tion. The data are available at the EuropeanNucleotide Archive
(ENA) under accession number ERP006812.
Analysis of Genes with High Differential Expression in TEU-2
Cells Overexpressing MiR-199a-5p—Transcriptomes from dif-
ferentiated TEU-2 cells transfected with miR-199a-5p were
compared with those of the controls transfected with non-tar-
geting miRNA to identify the effects of miR-199a-5p on gene
expression. We observed differential expression of 1646 genes
(3540 RefSeq ID) with 590 genes up-regulated and 1056 genes
down-regulated in the miR-199a-5p-transfected TEU-2 cells
(see supplemental file mRNA-seq reads.xlsx) (p value 0.05,
false discovery rate 0.05, -fold change 1.5). A heat map of
those 1646 significant differentially expressed genes is shown in
Fig. 1A. Hierarchical cluster and heatmap analyses consistently
grouped the samples into two clusters: Cluster I, miR-199a-5p-
transfected TEU-2 cells; Cluster II, non-targeting miR-Cy3-
transfected controls.
The genes with q value0.4, which were considered for fur-
ther study, are listed in supplemental file Selected genes for
QPCR.xlsx. These included themiR-199a-5p target genes iden-
tified previously (17) as well as genes expressed in TEU-2 cells
and predicted to be targeted bymiR-199a-5p using TargetScan,
TarBase, miRecords, and Ingenuity Knowledge Base data-
bases. Other genes identified via the RNA-seq experiment were
considered potentially novelmiR-199a-5p-responsive genes. In
addition to the down-regulated genes, mostly corresponding to
the previously described or predictedmiR-199a-5p targets such
as LIN7C, PALS1, DDR1, and JAG1, we observed a number of
mRNAs whose expression levels were significantly up-regu-
lated in miR-overexpressing TEU-2 cells compared with the
similarly differentiated controls (COL4A1, COL1A1, FN1,
SMTN, TGFBR1, and TGFBR3) (Fig. 1B).
RNA-seq-based and in Silico Pathway Analysis of Differenti-
ated TEU-2 Cells Overexpressing MiR-199a-5p—To identify
the significant pathways represented by the 1645 genes with
differential expression, a pathway analysis was conducted using
GeneGoMetaCore from Thomson Reuters (version 6.19, build
65960). Among the top 50 pathway maps enriched in genes
with differential expression, alteration of cell cycle; TGF,WNT,
and cytoskeletal remodeling; and cell adhesion signaling path-
ways were mostly notable (supplemental file Pathway analy-
sis.xlsx, sheet All regulated mRNA from mRNA-seq). To
account for the possible differentiation-related effects, we per-
formed two additional types of in silico pathway analysis, one
using all validated and top scoremiR-199a-5p targets as defined
by TargetScan, TarBase, miRecords, and Ingenuity Knowledge
Base databases (supplemental file Pathway analysis.xlsx, sheet
All miR-199a-5p targets), and the other using only the miR-
199a-5p-targeted mRNAs expressed in TEU-2 (supplemental
file Pathway analysis.xlsx, sheet Targets present in TEU2).
Analysis of the intersection of the 50 top pathway maps
revealed eight elements with cytoskeleton remodeling via TGF
and WNT achieving the highest score (Table 1).
Verification of the MiR-199a-5p-responsive Genes by QPCR
in Differentiated TEU-2 Cells and Monolayers—Tight junction
assembly in TEU-2 cells is accompanied by the formation of a
multilayered epithelium and differentiation-induced gene
expression alterations (17). These changes overlap with
miRNA-induced effects; therefore, we selected a subset of the
top differentially expressed genes representing predicted miR-
199a-5p targets, contractile and cytoskeletal proteins, and dif-
FIGURE 3.Down-regulationof endogenousmiR-199a-5p inbladder SMCsdecreases cell size and increases proliferation.A, antimiR-199a-5p effectively
inhibits miR-199a-5p in the target binding luciferase assay. The perfectly complementary binding site for miR-199a-5p (target) was cloned into pmirGLO
luciferase reporter vector and transfected into HEK293 cells stably transduced with lentiviruses expressing miR-199a-5p, antimiR-199a-5p, or scrambled miR
control.Renilla luciferase activity expressed from the samevectorwas used for normalization, and thedatawere expressed relative (rel.) to thenegative control
pmirGLO vector. Error bars represent S.E. (*, p 0.05). B, cultured primary human bladder SMCs (passage 1) were transduced with lentiviruses overexpressing
scrambled miRNA control (RFP reporter) or antimiR-199a-5p (GFP reporter) and co-transduced with miR-199a-5p and antimiR-199a-5p. Cells were passaged
once and examined live under an LSMmicroscope. Scale bars, 50 m. Images of cells collected from random fields (n 100 cells) were measured. The graph
shows the average value in each sample
S.D. (error bars) (**, p 0.005). C, 3 104 cells were seeded perwell, and cell countwas analyzed 7 days postplating.
Alternatively, cells were labeled with BrdU for 24 h, and a colorimetric proliferation BrdU ELISA was performed. Data are shown as -fold increase related to the
initial plating density (left graph) or normalized optical density (right graph)
S.D. (error bars) (**, p 0.005).
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ferentiation and proliferation regulators (including MX2,
DDR1, ZBP1, DCN, BGN, SM22, JAG1, FN1,VIM, COL4A1,
and SNAIL), for a follow-upQPCR. Fig. 1C shows a heatmap of
the QPCR data for 66 genes analyzed. Not all the gene
expression changes that were significant in the miR-199a-5p-
overexpressing differentiating TEU-2 cells persisted in the
miR-overexpressing monolayer TEU-2 cells. However, most
miR-199a-5p target genes, including LIN7C, ARHGAP12,
PALS1, DDR1, and the regulatory JAG1, connective tissue
growth factor (CTGF), and SNAIL were similarly regulated
regardless of differentiation (Fig. 1D), and the overall regulatory
pattern indicated that miR-199a-5p had a profound effect on
the transcriptome of the transfected TEU-2 cells regardless of
differentiation status.
Culturing of the Bladder SMCs Affects Contractile and Regula-
tory Proteins and Down-regulates Endogenous MiR-199a-5p—
Previously, using laser microdissection, we showed that miR-
199a-5p was detected in the mature bladder urothelium, and its
expression could be up-regulated following activation of cAMP
signaling pathways (17). However, its levels in the urothelium are
much lower than in the bladder smooth muscle (17), implying an
important regulatory role for miR-199a-5p in SMCs.
Cultured bladder SMCs undergo a rapid dedifferentiation
accompanied by the loss of contractility and cytoskeletal
remodeling (25). We raised primary cultures of the bladder
SMCs and assayed thembyQPCR formRNA levels of contract-
ile and regulatory proteins as well as miR-199a-5p (Fig. 2).
Already passages 1 and 3 of bladder SMCs displayed a signifi-
cant down-regulation of caldesmon, SM22, smoothelin, SM
-actin, SMmyosin, calponin, and P2X1 receptor mRNAs (Fig.
2A). Consequently, the ratio of MYH11 SM2/SM1 isoforms,
which is indicative of the differentiated state of the bladder
smooth muscle (26), was progressively reduced along with the
overall SM myosin heavy chain content (Fig. 2B). As the cells
regained proliferative activity, the mRNA levels of cyclin D1
and SNAIL were increased along with the ECM components
vimentin, fibronectin, and biglycan (Fig. 2, C and D). We also
detected an up-regulation of the validatedmiR-199a-5p targets
LIN7C, ARHGAP12 (17), and WNT2 (27) (Fig. 2E). Impor-
tantly, culturing of the bladder SMCs caused a significant
down-regulation of miR-199a-5p expression levels (Fig. 2F).
Although these data do not establish a causative link among SM
dedifferentiation, down-regulation of miR-199a-5p expression
levels, and up-regulation of WNT2 and its effectors, they
prompted us to address the potential involvement of theWNT2
regulator miR-199a-5p in SMC differentiation and function.
Inhibition of Endogenous MiR-199a-5p Significantly Decreases
Cell Size and Increases SMC Proliferation—To investigate the
role of miR-199a-5p in smooth muscle gene expression and
function, we altered its levels in primary SMCs using lentivi-
ruses, overexpressing miR-199a-5p or the inhibitory antimiR-
199a-5p constructs. To assess the effectiveness of miR-199a-5p
induction or inhibition, we first tested the lentivirus constructs
in the luciferase assay in HEK293 cells transfected with pmiR-
GLO-miR-199a target vector (17). Cells transduced with lenti-
viruses expressing scrambled miR or antimiR-199a-5p did not
show an inhibition of the luciferase activity, whereas the lenti-
virus overexpressing miR-199a-5p as expected significantly
reduced luciferase activity, confirming the synthesis of the
mature miRNA (Fig. 3A). Co-transduction of HEK293 with
miR-199a-5p and scrambled miR-expressing lentiviruses did
not significantly alter the luciferase inhibition, whereas in the
cells co-expressing miR-199a-5p and antimiR-199a-5p, the
luciferase activity was significantly higher than in miR-199a-5p
alone, confirming the effective attenuation of thismiRNAby its
antimiR (Fig. 3A).
We transduced low passage bladder SMCs with the scram-
bled miR control (tagged with RFP), antimiR-199a-5p (tagged
with GFP), or both miR-199a-5p and antimiR-199a-5p and
studied the cellmorphology by live cell imaging (Fig. 3B). SMCs
expressing antimiR-199a-5p were significantly smaller than
controls, and co-expression of antimiR with miR-199a-5p
effectively rescued this phenotype (Fig. 3B, graph). In addition
to the reduced cell size, antimiR-199a-5p-expressing SMCs had
a significantly increased proliferation rate compared with the
scrambled control and miR-199a-5p as evident by cell count
increase and elevated incorporation of BrdU in the antimiR
cells (Fig. 3C). These results indicate that the inhibition of the
endogenous miR-199a-5p in the smooth muscle has profound
morphological and proliferative effects.
To evaluate the changes in gene expression resulting from
the inhibition ofmiR-199a-5p, we analyzed a panel of predicted
and validated miRNA targets and contractile and regulatory
proteins by QPCR (Fig. 4A). The heat map summarizes the
results of these experiments. The samples of each group (anti-
miR, miR-199a-5p, and miR  antimiR) clustered together,
indicating similarities in gene expression regulation. Validated
and high score miR-199a-5p target genes LIN7C, ARHGAP12,
PALS1, WNT2, and DDR1 were down-regulated in miR-199a-
5p-overexpressing SMCs, up-regulated in antimiR-199a-5p-
expressing cells, and normalized in miR  antimiR samples
compared with the scrambled miR control (Fig. 4B). Interest-
ingly, mRNAs encoding CTGF, transcription factor SNAIL,
and ECM protein vimentin as well as integrin A2 were signifi-
cantly up-regulated in the SMCs transduced with antimiR-
199a-5p lentivirus (Fig. 4B).
WNT2 Is Regulated by MiR-199a-5p in Bladder SMCs—
Many of the proteins up-regulated following miR-199a-5p
attenuation, including vimentin, CTGF, and SNAIL, are known
components of the WNT signaling pathway. WNT2 is down-
FIGURE 4.MiR-199a-5p and antimiR-199a-5p have opposite effects on gene expression in bladder SMCs.A, heatmap comparing expression of 66 genes
in three groups of bladder SMCs: SMCs passage 3 transduced with miR-199a-5p lentivirus (miR RFP P3), antimir-199a-5p virus (AntimiR 199), andmiR-199a-5p
and antimiR-199a-5p double transduced virus (miRandAntimiR) (n 3 samples per group). The expression levels of genes are shown as -fold changes relative
(rel.) to control (scrambled miRNA). The square root of the Euclidian distance after centering and rescaling the data (1	 Pearson’s correlation) was used to
calculate the distance for clustering of the genes and samples. The rows correspond to genes, and the columns represent the experimental samples. B, the
graph shows gene expression changes of the validated and high score miR-199a-5p targets and regulated ECM proteins and factors as the averages of
triplicates of three independent transduction experiments related to the expression levels of the same genes in the scrambled miR-transduced control
samples. Error bars represent S.E. (*, p 0.05).
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regulated by miR-199a-5p and up-regulated by antimiR-199a-
5p, consistent with the previous studies validating it as a miR-
199a-5p target (27). The pathway analysis of miR-199a-5p-
overexpressing TEU-2 cells revealed regulation of the WNT
pathway (Table 1), prompting us to investigate the contribution
of WNT2 signaling to the morphological and proliferative
effects of miR-199a-5p and its antimiR inhibitor.
We tested a panel of WNT2-specific shRNAs and selected
two clones effectively down-regulating the endogenousWNT2
mRNA levels in SMCs (Fig. 5A). Although the overexpression
ofmiR-199a-5p reduced and that of antimiR-199a-5p increased
WNT2 mRNA levels (Figs. 4B and 5B), the co-expression of
antimiR-199a-5p andWNT2 shRNA in the co-transduced pri-
mary SMCs reversed the antimiR-mediated increase of WNT2
FIGURE 5.WNT2-specific shRNAs reduce antimiR-199a-5p-mediatedup-regulationofWNT2andnormalize cell size andproliferation rates.A, WNT2 is
down-regulated by WNT2 shRNA clones 2 and 3. Bladder SMCs primary cultures (passage 1) were stably transduced with lentiviruses expressing different
shRNAs specific for the WNT2 sequence. The levels of WNT2 mRNA were analyzed by QPCR in triplicates and compared with the scrambled non-interfering
shRNA control. Error bars represent S.E. (**, p 0.005). B, WNT2-specific shRNAs reduce the antimiR-199a-5p-mediated up-regulation of WNT2. Bladder SMCs
were transduced with lentiviruses expressing scrambledmiR, miR-199a-5p, or antimiR-199a-5p or co-transduced with antimiR andWNT2 shRNA clone 3. The
levels of WNT2 mRNA were analyzed by QPCR and compared with the scrambled miRNA control. Shown are the averages of three separate transduction
experiments each performed in triplicate. Error bars represent S.E. (**, p 0.005). C, SMCs transduced with scrambled shRNA or WNT2 shRNA clones 2 and 3
were examined using an LSM. Scale bars, 50m.D, cell surface area wasmeasured (n 100 cells). Graphs show the averages
 S.D. (error bars) (*, p 0.05; **,
p 0.005). E, bladder SMCs individually expressing scrambled miR (RFP tag), miR-199a-5p (RFP tag), or antimiR-199a-5p (GFP tag) and bladder SMCs co-ex-
pressing antimiR-199a-5p (GFP tag) andWNT2 shRNA clone 2 or 3 (mCherry tag) were observed using an LSM at the samemagnification. Scale bars, 50m. F,
n 100 cellsweremeasured in individually transducedor co-transduced SMCs. Thegraph shows the average cell surface area in each sample
S.D. (error bars)
(*, p 0.05;**, p 0.005). G, the bladder SMCs expressing scrambledmiR, miR-199a-5p, or antimiR-199a-5p or co-expressing antimiRWNT2 shRNA clone 2
(cl2) or 3 (cl3) were seeded in triplicates at 6 104 cells/well, and cell count was analyzed 5 days postplating. Data are shown as -fold increase relative to the
initial plating density
S.D. (error bars) (*, p 0.05).
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levels (Fig. 5B). We studied the effects of WNT2 down-regula-
tion on the bladder SM cellmorphology (Fig. 5C) and show that
WNT2 inhibition did not change the overall cell size (Fig. 5D).
To investigatewhether themorphological effects of antimiR-
199a-5p were due solely to the up-regulation of WNT2
expression,we transduced bladder SMCswithmiR-199a-5p- or
antimiR-199a-5p-overexpressing lentiviruses as well as
co-transduced antimiR-199a-5p with WNT2 shRNA-express-
ing constructs (clones 2 and 3 were used in separate experi-
ments). Compared with the scrambled miR, overexpression of
miR-199a-5p caused a significant increase in the SM cell size
(Fig. 5, E and F); overexpression of antimiR-199a-5p reduced
the cell size (Fig. 5, E and F), whereas antimiR together with
WNT2 shRNA clones 2 and 3 restored cell size to the control
values (Fig. 5, E and F). Similarly, the normalization of WNT2
expression levels following co-expression of antimiR-199a with
WNT2 shRNA reduced the proliferation rates back to the con-
trol levels (Fig. 5G).
Manipulation of WNT2 Levels in the AntimiR-199a-5p-ex-
pressing Cells Affects the Expression of WNT2 Signaling Path-
way Components—To examine whether the rescue of the
morphology and proliferation rates by WNT2 shRNAs in anti-
miR-199a-5p-experessing SMCs was due to the attenuation of
the WNT signaling pathway, we investigated the mRNA levels
of the miR-199a-5p target proteins and genes regulated by
WNT2 as well as contractile proteins. With the exception of
WNT2 itself, all other validated miR-199a-5p targets remained
unaffected by the shRNA-mediated decrease of WNT2 mRNA
levels (Fig. 6A). Conversely, contractile proteins and SMmark-
ers SM -actin, SM myosin heavy chain (isoforms SM1 and
SM2), and SM22 protein observed to be up-regulated in miR-
199a-5p-expressing cells were not strongly altered in antimiR-
199a-5p-expressing cells compared with scrambled miR con-
trol (Fig. 6A). Importantly, the up-regulated mRNA levels of
WNT-dependent proteins SNAIL1, JAG1, CTGF, cyclin D1,
and vimentin were significantly attenuated after the addition of
WNT2 shRNA (Fig. 6B). These results show that the compo-
nents of theWNT signaling pathway and genes up-regulated as
the result of its activation are controlled by miR-199a-5p via its
ability to influence WNT2 levels.
Overexpression of MiR-199a-5p in Bladder SMCs Increases
the Expression of Contractile and Cytoskeletal Elements via
Inhibition of WNT2—Cytoskeleton remodeling pathways were
high on the list of the top miR-199a-5p-dependent pathways in
TEU-2 cells (Table 1), and an up-regulation of SM markers
smoothelin and SM22 was detected in miR-overexpressing dif-
ferentiated TEU-2 cells bymRNA-seq (Fig. 1B) andQPCR (Fig.
1C). Previously, we have observed a significant increase in stress
fiber formation in miR-199a-5p-overexpressing TEU-2 cells
(17), indicating cytoskeletal rearrangements.
We modulated the levels of the endogenous miR-199a-5p
using recombinant lentiviruses and examined the filamentous
actin in the bladder SMCs. The cells overexpressing miR-
199a-5p showed prominent actin stress fibers (Fig. 7A). Inter-
estingly, the down-regulation of WNT2 with specific shRNAs
also caused strong stress fiber formation accompanied by cell
spreading (Fig. 7A). In contrast, the cells overexpressing anti-
miR-199a-5p, although smaller in size, displayed a less pro-
nounced phalloidin staining, and the actin fiber formation was
restored along with the cell size increase in antimiR WNT2
shRNA-co-transduced SMCs (Fig. 7B). ThemRNA levels of SM
-actin, SM myosin heavy chain isoforms, and SM22 were sig-
nificantly up-regulated in the miR-199a-5p-overexpressing
cells (Fig. 7C). The protein levels of SMmyosin heavy chain and
SM -actin were also considerably elevated, whereas the
smooth muscle-nonspecific l-caldesmon remained unchanged
in the examined samples (Fig. 7D). The levels of h-caldesmon
are rapidly decreased in cultured SMCs compared with the
functional smooth muscle (28). We observed an up-regulation
of h-caldesmon in miR-199a-5p-overexpressing SMC and its
significant down-regulation in antimiR-expressing cells (Fig.
7E), indicating an antimiR-induced acceleration of SMC
dedifferentiation.
MiR-199a-5p Promotes the Expression of MRTF-A-depen-
dent Smooth Muscle Regulatory Id3 Protein—Activation of
cytoskeleton remodeling pathways in miR-199a-5p-overex-
pressing SMCs impelled us to investigate the involvement of
the actin dynamics-responsiveMRTF-A in the gene expression
regulation of smooth muscle-specific contractile proteins. We
observed an increase in the levels of Rac1 activation (Fig. 8A)
and some nuclear localization of MRTF-A in miR-199a-5p
SMCs (Fig. 8B, arrows). MRTF-A exerts it functions following
nuclear relocalization rather than an expression level increase
(29); consequently, we did not detect significant changes of
MRTF-A mRNA levels in miR-199a-5p-expressing cells (Fig.
8C). However, there was a significant up-regulation of tran-
scription of MRTF-A-dependent myosin regulatory light chain
9 (MYL9) (30) and Id3 (31) (Fig. 8C).
Id3 is an important regulator of smooth muscle differentia-
tion program (32). It is localized in the nucleus of bladder SMCs
(Fig. 8D), and Id3 protein levels are increased in miR-199a-5p-
overexpressing cells (Fig. 8E), consistent with an increase of SM
differentiation markers MYH11, ACTA2, and SM22.
Increased Expression of Myocardin and Myocardin-stimu-
lated Genes in MiR-199a-5p-overexpressing SMCs—SM -ac-
tin, SM myosin heavy chain, SM22, and h-caldesmon are
induced by serum response factor (SRF) in complex with its
transcriptional co-activator myocardin; therefore, to under-
stand the mechanisms of miR-199a-5p-induced up-regulation
of their gene expression (Fig. 7), we studied the expression of
FIGURE 6. Co-expression of antimiR-199a-5p andWNT2 shRNA affects theWNT2-regulated genes but not the other miR-199a-5p targets. Shown are
heat map and cluster analysis of bladder SMCs (passage 3) transduced with scrambled miR virus (control), miR-199a-5p virus (eight replicates (Rep); miR),
antimir-199a-5p virus (eight replicates; AntimiR), and antimir-199a-5p co-transduced withWNT2 shRNA (four replicates; antimiRWNT shRNA). -Fold change
values relative (rel.) to the scrambled miR control were used for heat map generation. The graphs show the average -fold change values of two independent
transduction experiments performed in triplicates for miR-199a-5p and antimiR samples and two transduction experiments performed in duplicates for
antimiRWNT2 shRNA clone 3 (cl.3)
S.E. (error bars) (*, p 0.05).A, results formiR-199a-5p targets and contractile and cell cycle proteins; B, results forWNT2
and the genes it regulates.
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myocardin in these cells. ThemRNA levels ofmyocardin and its
regulated genes SM -actin (ACTG2), desmin (DES), trans-
forming growth factor-1-induced transcript 1 (TGFB1I1), and
cell cycle inhibitory protein p21 (CDKN1A) were significantly
up-regulated in miR-199a-5p-overexpressing SMCs (Fig. 9A).
Myocardin was also increased at the protein level (Fig. 9B), and
its nuclear localization was confirmed by immunofluorescence
(Fig. 9C).
Although antimiR-expressing cells show myocardin mRNA
levels similar to control levels, we observed a down-regulation
of myocardin targets desmin, TGFB1I1, and h-caldesmon
indicative of the inhibition of myocardin-mediated gene
expression. We analyzed the mRNA levels of myocardin inhib-
itors ELK1, FOXO4, andKrüppel-like factor 4 (KLF4) and show
a significant up-regulation of KLF4 mRNA levels in the anti-
miR-199a-5p-expressing SMCs (Fig. 9D) and a concomitant
reduction of its transcription in miR-199a-5p-overexpressing
cells. KLF4 is a WNT-dependent gene (33), and its expression
pattern was consistent with that of Axin2, anotherWNT target
(Figs. 9D and 8C).
Modulation of WNT2 Signaling in Bladder SMCsMimics the
Morphologic and Proliferative Effects of MiR-199a-5p Expres-
sion Changes—Having established that the up-regulation of
WNT2was the crucial factor responsible for themorphological
and proliferative effects of miR-199a-5p inhibitor, we sought to
model these changes by ectopically overexpressingWNT2 pro-
tein. The cDNA sequence of humanWNT2was PCR-amplified
and expressed as a fusion with copepod Pontellina plumata
copGFP, which acted as a direct reporter of the protein expres-
sion. Transduced bladder SMCs showed a significant increase
ofWNT2 expression at themRNAandprotein levels (Fig. 10A).
Analysis of cell size and morphology revealed similarities
between antimiR-199a-5p- and WNT2-overexpressing cells
(Fig. 10B); both caused a significant reduction of cell size com-
pared with the scrambled miR control (Fig. 10C).
The effect of activation and inhibition of WNT signaling
pathway was further tested in control and transduced SMCs
exposed to recombinant humanWNT 2 protein (100 ng/ml) or
DKK1 protein (50 ng/ml) for 48–72 h. Incubation of scrambled
miR-, miR-199a-5p-, and antimiR-199a-5p-expressing SMCs
with recombinant WNT2 caused a significant decrease of cell
size (Fig. 10,D and E) and an increase in proliferation rates (Fig.
10F). Addition of WNT inhibitor DKK1 did not significantly
alter the size of the control- or miR-199a-5p-expressing cells
with low endogenous WNT levels (Fig. 10E); however, DKK1
had a pronounced effect on the antimiR-expressing cells where
it antagonized the activated WNT signaling and as a conse-
quence significantly increased the cell size, bringing it close to
the control level (Fig. 10, D and E).
Activation and inhibition of WNT signaling in WNT2- and
DKK1-treated SMCs was confirmed by QPCR of WNT-regu-
lated genes Axin2 and KLF4 (Fig. 10G). Axin2 was significantly
up-regulated in the WNT2-treated SMCs and down-regulated
in the DKK1-treated SMCs, andKLF4 showed a tendency to be
up-regulated in the WNT2-treated SMCs and a significant
down-regulation in the DKK1-treated cells.
DISCUSSION
MicroRNAmiR-199a-5p is expressed in a broad array of tis-
sues, including the brain, liver, vascular and visceral smooth
muscle, ovarian and testicular tissue, cardiomyocytes, and
endothelial cells (34). In cardiomyocytes, it down-regulates
hypoxia-inducible factor 1 and sirtuin 1 (35) and is one of the
factors regulating cell size: its overexpression in cardiomyo-
cytes leads to hypertrophy (36). It is transcribed as antisense to
dynamin 3 within introns on chromosome 1 (1q24.3) and
dynamin 2 on chromosome 19 (27, 37). Expression of miR-
199a-5p is regulated by a variety of stimuli: hypoxia and AKT
signaling cause its rapid decrease and an up-regulation of its
targets (35). Activation of the cAMP-PKApathway for example
following stimulation of 2-adrenergic receptors induces miR-
199a-5p synthesis in cardiomyocytes and bladder urothelium
(17). TGF, which is increased in the majority of diseases
accompanied by fibrosis (38, 39), is another strong inducer of
miR-199a-5p synthesis. MiR-199a-5p attenuated expression of
CAV1, a critical mediator of pulmonary fibrosis (40), implicat-
ing it in the pathogenesis of fibrosis in lung and hepatic tissue.
Previously, we have shown that upon overexpression in
urothelial and bronchial epithelial cells miR-199a-5p impaired
correct tight junction formation and led to an increased epithe-
lial permeability due to a significant down-regulation of LIN7C,
ARHGAP12, PALS1, RND1, and PVRL1, the key proteins
involved in tight junction, adherens junction, and actin dynam-
ics (17). The expression of miR-199a-5p in differentiating
TEU-2 cells led to cell flattening and delayed formation of a
multilayered epithelium and induced stress fibers. Notably, the
effects ofmiR-199a-5p during adherens junction/tight junction
formation were pleiotropic as the rescue experiments with
some of its target proteins ameliorated but did not abolish the
miR-199a-5p-induced decrease of urothelial integrity.
Here we carried out a comprehensive mRNA-seq analysis
of the TEU-2 urothelial cell line overexpressing miR-
199a-5p and demonstrated 1646 genes differentially
expressed following miRNA transfection (p value 0.05,
FIGURE 7.MiR-199a-5p influences actin dynamics and increases levels of SM-specific contractile proteins. Fibrillar actin was stained in fixed, permeabi-
lized SMCs using Alexa Fluor 488-conjugated (A) or Cy3-conjugated (B) phalloidin. Images were taken at the samemagnification, exposure, and amplifier gain
settings. Scale bars, 50 m. C, mRNA levels of SM -actin, myosin heavy chain SM isoforms SM1 and SM2, and SM22 protein were analyzed by QPCR in the
samples of bladder SMCs expressingmiR-199a-5p or antimiR-199a-5p or co-expressing antimiR withWNT2 shRNA clone 3 and compared with the scrambled
miR control. Shown are data of two independent lentivirus transductions in triplicates 
S.E. (error bars) (*, p  0.05; **, p  0.005). D, the miR-199a-5p-,
antimiR-199a-5p-,WNT2-, and control scrambled (scr)miR-expressing cell lysateswere analyzedby SDS-PAGEunder equal loading (20gof total protein/lane)
followed by Western blotting with anti-SM myosin, anti-SM -actin, and anti-caldesmon antibodies as specified. The protein levels were quantified as
described under “Experimental Procedures.” The intensity of each band of interest was normalized to Amido Black staining (shown) and related to the
scrambled miR. The graphs show an average of three experiments
S.E. (error bars). Statistically significant differences from the scrambled miR control are
indicated (*, p  0.05). E, the bladder SM sample and the scrambled miR-, miR-199a-5p-, and antimiR-199a-5p-expressing SMC lysates were analyzed by
Western blotting with anti-caldesmon antibody. The bands of h- and l-caldesmon are indicated. The intensity of the h-caldesmon band in SMC samples was
normalized to l-caldesmon and related to the normalized scrambledmiR values. The graph shows an average of six experiments
S.E. (error bars). Statistically
significant differences from the scrambled miR control are indicated (*, p 0.05; **, p 0.005). overex, overexpressing.
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false discovery rate0.05). The pathway analysis performed
using the full transcriptome data as well as bioinformatics
predictions of the validated and high score miR-199a-5p tar-
gets genes, including those expressed in TEU-2 cells, identi-
fied TGF, WNT, and cytoskeletal remodeling as the major
miR-199a-5p-regulated pathway.
FIGURE 8. Activation of MRTF-A-dependent gene expression in miR-199a-5p-overexpressing SMCs. A, levels of basal and activated Rho GTPases RhoA,
Rac1, and Cdc42 were measured in scrambled miR- and miR-199a-5p-transduced SMCs using G-LISA as recommended by the manufacturer. Shown are
averages of three experiments. Error bars represent S.E. (*, p 0.05). B, localization ofMRTF-A in transduced SMCs (red) was examined by immunofluorescence
with anti-MRTF-A monoclonal antibodies (green). Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). Arrows indicate MRTF-A-positive nuclei of
miR-199a-5p-expressing cells. Scale bars, 50m. C, mRNA levels of MRTF-A, its targets MYL9 and Id3, ROCK2, andWNT-dependent Axin2 were determined by
QPCRandexpressed as -fold ratio to scrambledmiR. Shownare averages of four independent transduction experiments each in triplicates. Error bars represent
S.E. (*, p 0.05; **, p 0.005). D, immunofluorescence staining of scrambled miR- and miR-199a-5p-transduced SMCs (red) with anti-Id3 antibodies (green).
Images were taken at the same settings (amplitude and detector gain). Scale bars, 50 m. E, scrambled (scr) miR-, miR-199a-5p-, and antimiR-199a-5p-
expressing SMC lysates were analyzed byWestern blotting with anti-Id3 antibody. The Id3 bandwas normalized to Amido Black staining of the same samples
and related to the normalized scrambled miR values. The graph shows an average of three experiments
S.E. (error bars). Statistically significant differences
from the scrambled miR control are indicated (*, p 0.05).
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Previously, we showed that miR-199a-5p was highly
expressed in the bladder smoothmuscle layer (17), indicative of
its importance for the bladder SMC function. Based on the con-
cept thatmiRNAs regulate signaling networks rather than indi-
vidual genes (41), we sought to validate our analysis of miR-
199a-5p-dependent pathways in a different cell system: human
bladder SMCs. Using primary cultures of bladder SMCs, we
show that, concomitant with SMC dedifferentiation, miR-
199a-5p expression decreased, and the levels of its target
mRNAs increased. To identify the signaling pathways affected
by this regulatory miRNA, we experimentally manipulated the
levels of the endogenous miR-199a-5p in the bladder SMC cul-
tures. Gene expression analysis of the miR-199a-5p- and anti-
miR-199a-5p-transduced SMCs confirmed the regulation of
genes identified in the differentiated andmonolayerTEU-2 cul-
tures ectopically expressing miR-199a-5p. Specifically, DDR1
and WNT2, previously validated as miR-199a-5p targets (27,
42), as well as LIN7C, ARHGAP12, and PALS1 shown in our
earlier study were significantly and reversely changed in the
bladder SMCs following the alteration of the endogenous
miRNA levels by overexpression of miR-199a-5p or antimiR-
199a-5p. In line with these data, another study demonstrated
that overexpression of miR-199a-5p led to decreased DDR1,
MMP2, N-cadherin, and vimentin expression (43). In contrast,
we did not observe an inhibitory effect of miR-199a-5p on
mRNA and protein levels of caveolin 1 (40) either in TEU-2
cells or in the bladder SMCs, which could be attributed to the
tissue specificity of the miRNA effects.
FIGURE9.Up-regulationofmyocardinandactivationofmyocardin-dependentgenesareaccompaniedby changes inKLF4expression.A,mRNA levels
of myocardin (MYOCD) and the genes it stimulates, SM -actin (ACTG2), desmin (DES), transforming growth factor-1-induced transcript 1 (TGFB1I1), and cell
cycle inhibitory protein p21 (CDKN1A) were analyzedbyQPCR, normalized to 28 S rRNA, and related to the levels in scrambledmiR-transduced cells. Shownare
the averages of four independent transduction experiments each in triplicates. Error bars represent S.E. (*,p0.05; **,p0.005).B, protein levels ofmyocardin
were determined by Western blotting with anti-myocardin antibody. The myocardin band was normalized to Amido Black staining of the same samples and
related to the normalized scrambledmiR values. The graph shows an average of three experiments
S.E. (error bars). Statistically significant differences from
the scrambled (scr) miR control are indicated (*, p 0.05). C, immunofluorescence staining of scrambled miR- and miR-199a-5p-transduced SMCs (red) with
anti-myocardin antibodies (green). Images were taken at the same settings (amplitude and detector gain). Scale bars, 50 m. D, mRNA levels of myocardin
repressors ELK1, FOXO4, and KLF4 were analyzed by QPCR, normalized to 28 S rRNA, and related to the levels in scrambled miR-transduced cells. Shown are
averages of four independent transduction experiments each in triplicates. Error bars represent S.E. (*, p 0.05).
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FIGURE 10.Modulation of WNT2 signaling in bladder SMCs and its effect on cell size, proliferation, and gene expression. A, overexpression (overex) of
WNT2 in bladder SMCs. QPCR was used to determine the mRNA levels of WNT2 in bladder SMCs expressing scrambled (scr) miR control, miR-199a-5p,
antimiR-199a-5p, andWNT2protein.Graphs show the results related to scrambledmiR control in three independent experiments
S.E. (**,p0.005).Western
blotting with anti-WNT2 polyclonal antibodies detects WNT2 protein in HEK293 cells transfected with WNT2-overexpressing plasmid and in bladder SMCs
transduced with WNT2-expressing lentivirus. The position of WNT2 protein is indicated with an arrow. B, WNT2-overexpressing bladder SMCswere imaged live
at the same magnification as scrambled miR control- and antimiR-199a-5p-expressing cells. Scale bars, 50 m. C, cell size of the WNT2- and antimiR-199a-5p-
expressing SMCs comparedwith the scrambledmiR control
S.D. (error bars) (**, p 0.005).D, scrambledmiR-, miR-199a-5p-, and antimiR-transduced SMCs were
treated with human recombinant WNT2 (100 ng/ml) and DKK1 (50 ng/ml) for 72 h before examining live using an LSM. Scale bars, 100 m. E, cell surface area was
measured (n 60 cells). Graphs show the averages
 S.D. (error bars) (*,p 0.05; **,p 0.005;ns, not significant). F, cell proliferation followingWNT2 treatmentwas
analyzed by a BrdU incorporation assay. Cells were seeded at 2 103 cells/well (n 6 permeasurement), grown for 72 h, and treatedwith recombinantWNT2 for a
further 48 h followed by BrdU labeling and a proliferation assay. The graph shows averages of threemeasurements. Differences from untreated scrambledmiR are
indicated(**,p0.005).G,mRNAlevelsofWNT-dependentAxin2andKLF4genesweredeterminedbyQPCRinuntransducedbladderSMCstreatedwithrecombinant
WNT2 or DKK1 for 48 h. Average (n 3) -fold differences from themRNA levels in untreated SMCs
S.E. (error bars) are shown (*, p 0.05).
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The pivotal role of WNT2-mediated signaling as the main
pathway influenced by miR-199a-5p in the bladder smooth
muscle was demonstrated by the gene knockdown and overex-
pression experiments. Attenuation of the endogenous miR-
199a-5p levels with antimiR caused a significant reduction of
the bladder SMC cell size and increased cell proliferation. We
show that these changes were caused by the loss ofmiR-specific
inhibition and the subsequent increase of WNT2 expression
levels, leading to up-regulation of its effectors cyclin D1, c-myc,
JAG1, and SNAIL. Although WNT2 is one among the numer-
ous miR-199a-5p-regulated proteins, the importance of its up-
regulation and the subsequent activation of theWNT signaling
pathway was confirmed by gene knockdown experiments:
when WNT2 levels up-regulated in the antimiR-199a-5p-ex-
pressing cells were restored by the co-expression of WNT2-
specific shRNAs, both the cell size and the proliferation rates
returned to control levels. In contrast, overexpression of
WNT2 protein or treating the cells with recombinant WNT2
caused effects similar to those of antimiR-199a-5p, leading to a
remarkable cell size reduction and accelerated proliferation.
Conversely, overexpressing miR-199a-5p in the bladder SMCs
caused a significant increase of the cell size, enhanced stress
fiber formation, and considerably increased the synthesis of
contractile and SM-specific proteins SM -actin, SM myosin,
SM22, and h-caldesmon. The importance of miR-199a-5p in
the regulation of the smooth muscle cell size reported here is
supported by an observation that its expression correlated with
hypertrophy, but not fibrosis, in hypertrophic cardiomyopathy
(44).
WNT/Frizzled/-catenin signaling regulates embryonic
development and tissue homeostasis, and its dysregulation is a
common cause of cancers (45). WNT2 plays a role in SM and
cardiac muscle differentiation: it is strongly up-regulated dur-
ing cardiomyocyte differentiation and plays a strong positive
stage-specific role in cardiogenesis through the non-canonical
WNT pathway in murine embryonic stem (ES) cells (46). Mice
deficient for WNT2 displayed vascular abnormalities, includ-
ing defective placental vasculature (47), and it was shown that
WNT2 signaling was necessary and sufficient for activation of a
transcriptional and signaling network critical for smooth mus-
cle specification and differentiation, including myocardin/
MRTF-B and the signaling factor FGF10 (48).WNT2 functions
at multiple stages of development during ES cell differentiation
and the commitment and diversification of mesoderm (49).
In contrast to embryonic development, in differentiated
SMCs, activation of WNT induced cell proliferation, whereas
its inhibition improved muscle contractility: a significant
induction of WNT2 andWNT4 mRNA was detected in prolif-
erating vascular SMCs (50), and inhibition of WNT signaling
improved contractile function in experimental models of myo-
cardial infarction (51). Our data support the latter finding: we
show thatWNT2 inhibition bymiR-199a-5p occurred simulta-
neously with activation of both myocardin- and MRTF-A-de-
pendent SM differentiation programs in SMCs overexpressing
miR-199a-5p.We propose that these effects originate from two
separate facets of miR-199a-5p function, namely its ability to
regulate the cytoskeleton dynamics, leading to the activation of
MRTF-A-induced gene expression, and its function as an
inhibitor of WNT signaling, resulting in the attenuation of
KLF4 synthesis (Fig. 11). KLF4 is a potent repressor of both
myocardin expression and myocardin-induced activation of
SM genes (52). It is not a direct target of miR-199a-5p, but as a
WNT-responsive gene (33), it is amendable to modulation fol-
lowing miR-199a-5p-mediated WNT2 down-regulation (Fig.
11). Our model does not exclude the involvement of further
miR-regulated pathways affecting the SRF/myocardin gene
expression program. Specifically, the link between KLF4 and
miR-199a-5p awaits further study.
Recently, it was shown that miR-199a-5p was regulated in an
SRF-dependent manner like the other muscle miRNAs, includ-
ing miR-1, miR-133a/b, miR-143, miR-145, miR-206, andmiR-
486 (53). Interestingly, similar tomiR-199a-5p, muscle-specific
miR-1 suppressesWNT signaling and promotes differentiation
of cardiomyocytes by modulating the activities of WNT and
FGF signaling pathways (54). Our results suggest the existence
of a positive feedback loop between SRF/myocardin and miR-
199a-5p that promotes the SM-specific gene expression.
FIGURE 11.Model of miR-199a-5p in smooth muscle differentiation and
hypertrophy. Increased expression of miR-199a-5p in smooth muscle cells
has two main consequences: it affects WNT signaling by down-regulating
WNT2 and influences cytoskeleton remodeling. 1) Inhibition of the WNT sig-
naling pathway leads to down-regulation of KLF4, a WNT-dependent repres-
sor of bothmyocardin synthesis and transcription of SRF/myocardin (Myocd)-
stimulated genes. The KLF4 decrease leads to elevation of myocardin levels;
together with SRF, myocardin then induces genes encoding SM-specific and
contractile proteins, including SM22, SM -actin (ACTA2), SM myosin heavy
chain (MYH11), and transforming growth factor-1-induced transcript 1
(TGFB1I1). 2) MiR-199a-5p-regulated cytoskeleton remodeling activates
actin-dependent MRTF-A, which translocates to the nucleus, associates with
SRF, and stimulates expression of MYL9 and Id3. Id3 is a part of a regulatory
network promoting smooth muscle differentiation. The resulting increase in
synthesis of contractile and structural proteins leads to SMC hypertrophy.
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Previously, miR-199a-5p has been described as a negative
regulator of keloid fibroblast (55) and endometrial mesenchy-
mal stem cell (56) proliferation. Our study demonstrates that
the ability of miR-199a-5p to modulate WNT signaling regu-
lates proliferation of the bladder smooth muscle.
In the striated muscle, overexpression of miR-199a-5p pro-
motedmyoblast but notmyotube proliferation (27), resulting in
abnormal myofiber disruption and inhibition of myogenic dif-
ferentiation. Here we report an increase of Id3mRNA and pro-
tein levels in miR-199a-5p-overexpressing SMCs. Id3 is an
important regulator of gene expression, playing a critical role in
SM differentiation (32, 57). Id3 has been shown to inhibit stri-
ated muscle differentiation, preventing myoblast-myotube
conversion (58) by antagonizing the promyogenic activities of
Myf5 and Pax7 (32). Up-regulation of Id3 observed here offers
an additional argument supporting the importance of miR-
199a-5p in dystrophic muscle.
Our results point to the crucial role of miR-199a-5p in the
WNT2-mediated regulation of proliferative and differentiation
processes in the bladder smooth muscle. Recent evidence sug-
gests that sustainedWNT pathway reactivation is linked to the
pathogenesis of fibrotic diseases (59). By regulating WNT-de-
pendent cytoskeleton remodeling pathways, miR-199a-5p may
behave as a key modulator of smooth muscle hypertrophy and
fibrosis, which are relevant for bladder organ remodeling.
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